Centri News & Insights

Learn about the latest accounting and business trends, dive into topics of interest, or discover what’s happening at Centri.

Sort By


CECL Accounting: Implementation & Challenges

What is current expected credit loss (CECL) and why is it important?...

Read More


5 Key Steps to Consider Before Your IPO

Is your company looking to go public? If so, it is time...

Read More


Centri Case Study: The Technical Expertise You Need for Adopting CECL

Challenge A public mortgage Real Estate Investment Trust (REIT) identified that, as...

Read More


5 Ways Accounting Transformation Can Help Your Business Achieve More

Accounting and finance leaders face increasing pressure to deliver fast reporting, manage...

Read More


Centri’s Mihir Jhaveri Featured in Compliance Week: More Companies Enter “Discovery Phase” of ESG Reporting in 2023

Centri’s Partner and Risk & Sustainability Practice Leader, Mihir Jhaveri, is featured...

Read More


Centri Names Gerald Wik to New Role as President

Centri Business Consulting, LLC, one of the industry’s fastest-growing and most respected...

Read More


Centri’s Jerry Maginnis Featured in Accounting Today: Stop Talking About the Talent Shortage and Start Solving it!

Centri’s Senior Advisor, Jerry Maginnis, is featured in an Accounting Today article:...

Read More


The Importance of FP&A and How Centri Can Help

Introduction Financial Planning and Analysis (FP&A) is a crucial aspect of any...

Read More


Bridging the GAAP: November 2023

Centri’s Bridging the GAAP newsletter focuses on news, developments, & emerging issues...

Read More


Valuing Contingent Value Rights in M&A Transactions

Contingent value rights (“CVRs”) remain popular instruments in M&A transactions to help...

Read More


Centri’s Cultivating Business: Positioning in a Competitive Market, featuring Stephen Abraham

Join Centri's Cannabis Practice Leader, Kevin McLaughlin, for the latest edition of...

Read More


Valuing Contingent Value Rights in Life Sciences Transactions

Contingent value rights (“CVRs”) remain popular instruments in life sciences transactions to...

Read More